CRBP

Corbus Pharmaceuticals Holdings Stock Analysis

AI Rating

Neutral
  • Quality3/10
  • Growth↓ 2/10
  • Value↓ 4/10
Corbus Pharmaceuticals Holdings sales and earnings growth
CRBP Growth
Fair
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -60.33%
  • FCF Y/Y↓ -54.32%
Corbus Pharmaceuticals Holdings gross and profit margin trends
CRBP Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ -69.37%
Corbus Pharmaceuticals Holdings net debt vs free cash flow
CRBP Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

Corbus Pharmaceuticals Holdings stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗